Biotech SF: IntegenX

Showing posts with label IntegenX. Show all posts

Monday, April 23, 2012

Pleasanton's IntegenX buys GE subsidiary

IntegenX Inc. will buy a wholly owned subsidiary of GE Healthcare Bio-Sciences, a move that the Pleasanton-based company said will help its DNA identification system get to market sooner. Financial terms of the deal around the intellectual property and the patent portfolio held by General Electric Co. subsidiary SV Corp. were not disclosed.

Tuesday, December 13, 2011

IntegenX raises $40M for human DNA ID system

IntegenX Inc. has raised $40 million in a Series C round of funding led by new investor Essex Woodlands.
Pleasanton-based IntegenX is focused on molecular biology and biotechnology.

Monday, March 7, 2011

IntegenX nearly doubles HQ in Pleasanton

IntegenX, a company focused on molecular biology and biotechnology, has expanded its space to 29,500 square feet in the Hacienda Business Park in Pleasanton.

Monday, February 7, 2011

IntegenX raises $15.6 million, buys GenVault

Subscribe to: Posts (Atom)

Some of my favorite stories.

• "The fight of his life" (2007)

Last year Mike Homer helped raise the money for 2,000 medical research computers. Now researchers are using that equipment in an attempt to save his life.

• "For reporter, CJD is more than a story" (2007)

Seven years ago -- nearly to the day -- my mother died of Creutzfeld-Jakob Disease.

• "A son's YouTube plea for Avastin" (2010)

Josh Turnage is your typical teenager, trying to discover what he wants to do in college and with his life. But a 7-minute, 41-second YouTube video he produced about his mother's fight with breast cancer may thrust him into a debate between drug makers and the agency that regulates them.

• "New device could knock out old dialysis technology" (2011)

Shuvo Roy has all the makings for the world's first implantable artificial kidney, thanks to nanotechnology and a web of nationwide collaborations.

All he needs now is $20 million.